Frontiers in Immunology (Apr 2021)

Neurological Symptoms of COVID-19: The Zonulin Hypothesis

  • Sílvia Llorens,
  • Sílvia Llorens,
  • Eduardo Nava,
  • Eduardo Nava,
  • Mónica Muñoz-López,
  • Mónica Muñoz-López,
  • Álvaro Sánchez-Larsen,
  • Tomás Segura,
  • Tomás Segura,
  • Tomás Segura

DOI
https://doi.org/10.3389/fimmu.2021.665300
Journal volume & issue
Vol. 12

Abstract

Read online

The irruption of SARS-CoV-2 during 2020 has been of pandemic proportions due to its rapid spread and virulence. COVID-19 patients experience respiratory, digestive and neurological symptoms. Distinctive symptom as anosmia, suggests a potential neurotropism of this virus. Amongst the several pathways of entry to the nervous system, we propose an alternative pathway from the infection of the gut, involving Toll-like receptor 4 (TLR4), zonulin, protease-activated receptor 2 (PAR2) and zonulin brain receptor. Possible use of zonulin antagonists could be investigated to attenuate neurological manifestations caused by SARS-CoV-19 infection.

Keywords